BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29297968)

  • 1. Comparison between core-shell and totally porous particle stationary phases for fast and green LC determination of five hepatitis-C antiviral drugs.
    Ibrahim AE; Hashem H; Elhenawee M; Saleh H
    J Sep Sci; 2018 Apr; 41(8):1734-1742. PubMed ID: 29297968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of a sensitive and robust strategy for micellar electrokinetic chromatographic analysis of sofosbuvir in combination with its co-formulated hepatitis C antiviral drugs.
    Rageh AH; Abdel-Aal FAM; Pyell U
    J Chromatogr A; 2020 Apr; 1616():460795. PubMed ID: 31918849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validated spectrophotometric and chromatographic methods for analysis of the recently approved hepatitis C antiviral combination ledipasvir and sofosbuvir.
    Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
    Ann Pharm Fr; 2018 Jan; 76(1):16-31. PubMed ID: 28842163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms.
    Ezzeldin E; Abo-Talib NF; Tammam MH; Asiri YA; Amr AEE; Almehizia AA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33050433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemometrically Assisted Development of Ultra-High-Performance Liquid Chromatography Method for the Simultaneous Quantification of Sofosbuvir, Daclatasvir and Ledipasvir in Pharmaceutical Dosage Forms.
    Labidi A; El Atrache LL
    J Chromatogr Sci; 2020 Jan; 57(10):910-919. PubMed ID: 31644804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of small size fully porous particles and superficially porous particles of chiral anion-exchange type stationary phases in ultra-high performance liquid chromatography: effect of particle and pore size on chromatographic efficiency and kinetic performance.
    Schmitt K; Woiwode U; Kohout M; Zhang T; Lindner W; Lämmerhofer M
    J Chromatogr A; 2018 Sep; 1569():149-159. PubMed ID: 30041874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a highly sensitive high-performance thin-layer chromatography method for the screening and simultaneous determination of sofosbuvir, daclatasvir, and ledipasvir in their pure forms and their different pharmaceutical formulations.
    Saraya RE; Elhenawee M; Saleh H
    J Sep Sci; 2018 Sep; 41(18):3553-3560. PubMed ID: 30048040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Band broadening in fast gradient high-performance liquid chromatography: application to the second generation of 4.6 mm I.D. silica monolithic columns.
    Gritti F; Guiochon G
    J Chromatogr A; 2012 May; 1238():77-90. PubMed ID: 22503619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies.
    Baker MM; Hammad SF; Belal TS
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1111-1119. PubMed ID: 30929537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid determination of parabens in seafood sauces by high-performance liquid chromatography: A practical comparison of core-shell particles and sub-2 μm fully porous particles.
    Ye J; Cao X; Cheng Z; Qin Y; Lu Y
    J Sep Sci; 2015 Dec; 38(23):3992-9. PubMed ID: 26383987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core-shell column Tanaka characterization and additional tests using active pharmaceutical ingredients.
    Ludvigsson JW; Karlsson A; Kjellberg V
    J Sep Sci; 2016 Dec; 39(23):4520-4532. PubMed ID: 27739648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limit of the speed-resolution properties in adiabatic supercritical fluid chromatography.
    Gritti F; Guiochon G
    J Chromatogr A; 2013 Jun; 1295():114-27. PubMed ID: 23672980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of core-shell particles and sub-2μm fully porous particles for use as ultrafast second dimension columns in two-dimensional liquid chtomatography.
    Haidar Ahmad IA; Soliven A; Allen RC; Filgueira M; Carr PW
    J Chromatogr A; 2015 Mar; 1386():31-8. PubMed ID: 25681829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast gradient screening of pharmaceuticals with 5 cm long, narrow bore reversed-phase columns packed with sub-3 μm core-shell and sub-2 μm totally porous particles.
    Fekete S; Fekete J
    Talanta; 2011 Apr; 84(2):416-23. PubMed ID: 21376967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elbasvir/grazoprevir, Velpatasvir/sofosbuvir, and Eteplirsen.
    Hussar DA; Tidwell WP
    J Am Pharm Assoc (2003); 2017; 57(1):129-132. PubMed ID: 28038699
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of peak capacity of microbore liquid chromatography columns using gradient kinetic plots.
    Hetzel T; Blaesing C; Jaeger M; Teutenberg T; Schmidt TC
    J Chromatogr A; 2017 Feb; 1485():62-69. PubMed ID: 28093205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectroflurimetric estimation of the new antiviral agent ledipasvir in presence of sofosbuvir.
    Salama FM; Attia KA; Abouserie AA; El-Olemy A; Abolmagd E
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Feb; 190():513-517. PubMed ID: 28968574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic evaluation of commercially available ultra-high performance liquid chromatography columns for drug metabolite profiling: optimization of chromatographic peak capacity.
    Dubbelman AC; Cuyckens F; Dillen L; Gross G; Hankemeier T; Vreeken RJ
    J Chromatogr A; 2014 Dec; 1374():122-133. PubMed ID: 25435462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrophotometric assessment of the brand new antiviral combination: Sofosbuvir and velpatasvir in their pure forms and pharmaceutical formulation.
    Rezk MR; Monir HH; Marzouk HM
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Apr; 213():159-166. PubMed ID: 30685554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of anti-Hepatitis C virus, sofosbuvir and daclatasvir, in pure form, human plasma and human urine using micellar monolithic HPLC-UV method and application to pharmacokinetic study.
    Zidan DW; Hassan WS; Elmasry MS; Shalaby AA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():73-81. PubMed ID: 29660665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.